Tuberous xanthoma in type 1 familial hypercholesterolemia
DOI:
https://doi.org/10.18203/2349-3291.ijcp20242350Keywords:
Tuberous, Xanthoma, Familial, Hypercholesterolemia, LDLAbstract
Familial hypercholesterolemia (FH) is a genetic disease in which there is high low‑density lipoprotein cholesterol levels due to mutation in the gene encoding the receptor for low-density lipoprotein (LDL) located on chromosome 19 and the patients are at high risk for cardiovascular disease, cerebrovascular accidents, metabolic syndrome, and premature coronary death. We present this rare genetic disorder in a 7-year-old boy. The clinicians should be aware of this condition as early diagnosis and treatment can reduce the morbidity and mortality rate associated with the condition.
References
Singh S, Bittner V. Familial hypercholesterolemia epidemiology, diagnosis, and screening. Curr Atheroscler Rep. 2015;17:482.
Paller AS, Mancini AJ. Inborn errors of metabolism. In: Hurwitz Clinical Pediatric Dermatology: A Textbook of Skin Disorders of Childhood and Adolescence. 5th edition. Canada: Elsevier Saunders. 2016;564.
Van Aalst Cohen ES, Jansen AC, de Jongh S, de Sauvage Nolting PR, Kastelein JJ. Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia. Semin Vasc Med. 2004;4:31-41.
Mabuchi H. Half a century tales of familial hypercholesterolemia (FH) in Japan. J Atheroscler Thromb. 2017;24:189 207.
Davidson MH. A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia. J Clin Lipidol. 2011;5:76 81.
Brown MS, Goldstein JL. A receptor mediated pathway for cholesterol homeostasis. Science. 1986;232:34 47.
Wiegman A, Gidding SS, Watts GF, Chapman MJ, Ginsberg HN, Cuchel M, et al. Familial hypercholesterolaemia in children and adolescents: Gaining decades of life by optimizing detection and treatment. Eur Heart J. 2015;36:2425 37.
Kolansky DM, Cuchel M, Clark BJ, Paridon S, McCrindle BW, Wiegers SE, et al. Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hyper-cholesterolemia. Am J Cardiol. 2008;102:1438 43.
Holzer G, Volc‐Platzer B. Skin Manifestations of Paediatric Metabolic Syndrome. In: Hoeger PH, Kinsler VA, Yan AC, Harper J, Oranje AP, Bodemer C, et al. Harper’s Textbook of Paediatric Dermatology, 4th edition. Hoboken, New Jersey: Wiley-Blackwell. 2019;841-58.
Widhalm K, Binder CB, Kreissl A, Aldover Macasaet E, Fritsch M, Kroisboeck S, et al. Sudden death in a 4 year old boy: A near complete occlusion of the coronary artery caused by an aggressive low density lipoprotein receptor mutation (W556R) in homozygous familial hypercholesterolemia. J Pediatr. 2011;158:167.
